Vanguard Group Inc Chroma Dex Corp. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Vanguard Group Inc holds 3,430,356 shares of CDXC stock, worth $18.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,430,356
Previous 3,386,425
1.3%
Holding current value
$18.7 Million
Previous $9.24 Million
35.44%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CDXC
# of Institutions
94Shares Held
17.2MCall Options Held
66.7KPut Options Held
8.2K-
Black Rock Inc. New York, NY3.12MShares$17 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.96MShares$16.1 Million5.59% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.07 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.27 Million0.0% of portfolio
-
State Street Corp Boston, MA618KShares$3.37 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $373M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...